Source: International Congress 2017 – Monitoring asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mukherjee (Hamilton, ON, Canada). Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab. 4768

Member's Comments

No comment yet.

Related content which might interest you: Can we treat Exercise Induced Laryngeal Obstruction with inhaled ipratropiumbromide? Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (APAP) Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis Year: 2020 Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Progressive Phenotype in Chronic Hypersensitivity Pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 LATE-BREAKING ABSTRACT: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Bronchial Rheoplasty Increases Distal Airway Volume in Chronic Bronchitis Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Chronic Airway Inflammation promotes de novo Sensitization to Inhaled Allergen by Persistent Activation of Dendritic Cells Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Interaction between RPL554 and glycopyrronium bromide in small human airways Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014